Nalu Medical Stock

www.nalumed.comHealthcare / Medical DevicesFounded: 2014Funding to Date: $281.71MM

Nalu Medical is a developer of neuropathic pain treatment technology. With a mission to use technology to improve the quality of life in patients with chronic pain, Nalu Medical creates medical devices for spinal cord stimulation and peripheral nerve stimulation through micro-implantable pulse generators. Nalu Medical was founded by Daniel Pivonka, Lee Hartley, and Mike Partsch in 2014 and is headquartered in San Diego, CA.

Register To Buy and Sell Shares

For more details on financing and valuation for Nalu Medical, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Nalu Medical’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Nalu Medical.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Nalu Medical investors also invested in these private companies


Management Team

Thomas West
Jeffrey Swiecki
Chief Financial Officer
Jon Ruais
Chief Market Development & Strategy Officer & Chief Commercial Officer
Lee Hartley Ph.D
Co-Founder & Chief Technical Officer
Allen Meacham
Chief Business Development Officer & Chief Revenue Officer
Bick Sellers
Chief People Officer
Keegan Harper
Daniel Pivonka Ph.D

Board Members

Geoff Pardo
Gilde Healthcare
Hugo Harrod
MVM Partners
Juliet Bakker
Longitude Capital
Maxwell Bikoff
Longitude Capital
Robert Barmann
Endeavour Vision
Toby AuWerter
Endeavour Vision

Frequently Asked Questions About Nalu Medical’s Stock

Can you buy Nalu Medical’s stock?
Nalu Medical is not publicly traded on NYSE or NASDAQ in the U.S. To buy Nalu Medical’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Nalu Medical’s stock?
Yes, you can sell stock of a private company like Nalu Medical. Forge can help you sell your Nalu Medical stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Nalu Medical’s stock price?
Nalu Medical is a privately held company and therefore does not have a public stock price. However, you may access Nalu Medical’s private market stock price with Forge Data.
What is Nalu Medical’s stock ticker symbol?
Nalu Medical does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Miniature neurostimulator developer Nalu Medical nets $65M VC round
Nalu Medical has collected $65 million in new financing to boost the reach and adoption of its miniaturized neurostimulation implant aimed at treating chronic pain. The California-based company’s series E round was led by a new backer in Novo Holdings; returning investors included Gilde Healthcare, MVM Partners, Endeavor Vision, Decheng Capital, Longitude Capital, Advent Life Sciences, Pura Vida and Aperture Venture Partners.
Updated on: Jun 13, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.